Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant ITGAL (Efalizumab Biosimilar) anticorps

Reactivité: Humain BR, FACS Hôte: Human Monoclonal hu1124 unconjugated Recombinant Antibody
N° du produit ABIN5668044
  • Antigène Tous les produits ITGAL (Efalizumab Biosimilar)
    ITGAL (Efalizumab Biosimilar)
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    Humain
    Hôte
    • 1
    • 1
    Human
    Clonalité
    • 2
    Monoclonal
    Conjugué
    • 2
    Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé
    Application
    Blocking Reagent (BR), Flow Cytometry (FACS)
    Specificité
    Binds to human LFA-1.
    Attributs du produit

    OriginalSpeciesName: Human

    OriginalFormat: IgG1

    Purification
    Purified antibody.
    Pureté
    > 98 % as determined by SDS-PAGE
    niveau d'endotoxine
    Endotoxin is < 1.0 EU/mg as determined by the LAL method
    Immunogène
    Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
    Clone
    Hu1124
    Isotype
    IgG1 kappa
  • Indications d'application
    Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.
    Restrictions
    For Research Use only
  • Buffer
    PBS with 0.02 % Proclin 300.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène
    ITGAL (Efalizumab Biosimilar)
    Abstract
    ITGAL (Efalizumab Biosimilar) Produits
    Synonymes
    anticorps CD11A, anticorps LFA-1, anticorps LFA1A, anticorps integrin subunit alpha L, anticorps ITGAL
    Classe de substances
    Biosimilar
    Sujet
    LFA-1, integrin alpha L
    UniProt
    P20701
Vous êtes ici:
Support technique